Israel Englander Pardes Biosciences, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.4 - $1.95 $283,575 - $394,980
202,554 Added 143.61%
343,595 $621,000
Q1 2023

May 15, 2023
BUY
$1.21 - $2.22 $110,148 - $202,091
91,032 Added 182.03%
141,041 $186,000
Q4 2022

Feb 14, 2023
BUY
$0.85 - $1.69 $7,843 - $15,595
9,228 Added 22.63%
50,009 $85,000
Q3 2022

Nov 14, 2022
SELL
$2.14 - $3.7 $85,698 - $148,170
-40,046 Reduced 49.55%
40,781 $75,000

Others Institutions Holding PRDS

# of Institutions
2
Shares Held
5.23M
Call Options Held
0
Put Options Held
0
View Full List

About PARDES BIOSCIENCES, INC.

PRDS Quotes by TradingView
  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email